Faeth Therapeutics is a cancer metabolism company developing clinically-tested nutrition control, therapeutics, and digital tools for the treatment of cancer. Founded in 2019 by leading researchers in Europe and the United States and backed by leading investors, the company is pioneering its work in cancer metabolism to support a radically new way to treat cancer. Faeth's research, published in peer-reviewed scientific journals, shows that tailoring the right diet to the cancer patient can significantly impact the efficacy of clinically tested therapeutics for cancer. Feed the fight.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/30/22 | $47,000,000 | Series A |
AgFunder Cantos Ventures Digitalis Ventures Future Ventures KdT Ventures S2G Ventures  | undisclosed |
